During the past decade, 3401 Market Street, Suite 202 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "3401 Market Street, Suite 202" #1 collaborator was "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator and "Robert Wood Johnson Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "3401 Market Street, Suite 202" are "Obesity" (2 trials), "Pregnancy" (2 trials), "Maternal-fetal Relations" (1 trials), "Physical Inactivity" (1 trials) and "Stress, Physiological" (1 trials). Many other conditions were trialed in "3401 Market Street, Suite 202" in a lesser frequency.

Most popular intervention types in "3401 Market Street, Suite 202" are "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Physical activity promotion" (1 trials) and "Weight Management" (1 trials). Other intervention names were less common.

The vast majority of trials in "3401 Market Street, Suite 202" are 3 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "3401 Market Street, Suite 202". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in 3401 Market Street, Suite 202, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in 3401 Market Street, Suite 202, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".